Clinical Trial Update: Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost [Phase 2]

View source ↗

Summary

A Phase 2 study comparing ALZ-1101 to Latanoprost in patients whose intraocular pressure remains inadequately controlled by Latanoprost has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Elevated Intraocular Pressure
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ALZ-1101
• Latanoprost (Latanoprost)

Snippet

Sponsor: Alleanza Pharmaceuticals, Inc. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED